What does DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE do?

DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE is a specialist medical practice in Nivelles. Private Limited, started on 29 January 2015, 1 establishment.

What is the address of DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE?

The registered office of DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE is located at Allée Pré Lorette 4, 1400 Nivelles.

Is DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE still active?

Yes. According to the CBE (1 October 2026) DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE is active, legal situation “Normale toestand”, started on 29 January 2015.

Is DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE registered on Peppol?

Yes, DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE is registered on the Peppol network with ID 0208:0597598885.

What is the enterprise number of DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE?

The enterprise number of DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE is BE0597598885.

When was DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE founded?

DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE was founded on 29 January 2015.

Who are the directors of DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE?

According to the 2025 annual accounts, the directors of DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE are: Dedobbeleer DR Chantal Dedobbeleer.

Is DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 January 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE make in 2025?

DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE posted a profit after taxes of € 96,432 in financial year 2025.

What is the revenue of DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE?

As a small company, DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 133,358.

DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE (Private Limited)

Dossier DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE, printed on 1 October 2026 from databakkes.be/en/0597598885/docteur-chantal-dedobbeleer-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE from Nivelles, company number BE0597598885, closed financial year 2025 with a result of € 96,432 after tax. For that financial year DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE recorded a gross margin of € 133,358 and equity of € 405,049. Compared with financial year 2024, the result moved from € 94,579 to € 96,432. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 4, 2026.

What it is worth Healthy

€ 405,049

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 96,432

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 89,158

▼ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 104,557 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

€ 20

▼ 93% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 5,241

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,694

▼ 50% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 105,313 Gross margin 2022: € 105,313 First fiscal year in the series	€ 135,329 Gross margin 2023: € 135,329 ▲ 29% vs 2022 (€ 105,313) Favourable step	€ 132,656 Gross margin 2024: € 132,656 ▼ 2% vs 2023 (€ 135,329) Unfavourable step	€ 133,358 Gross margin 2025: € 133,358 ▲ 1% vs 2024 (€ 132,656) Favourable step	▲ 1%
Profit after taxes	€ 66,176 Profit after taxes 2022: € 66,176 First fiscal year in the series	€ 84,815 Profit after taxes 2023: € 84,815 ▲ 28% vs 2022 (€ 66,176) Favourable step	€ 94,579 Profit after taxes 2024: € 94,579 ▲ 12% vs 2023 (€ 84,815) Favourable step	€ 96,432 Profit after taxes 2025: € 96,432 ▲ 2% vs 2024 (€ 94,579) Favourable step	▲ 2%
Equity	€ 233,779 Equity 2022: € 233,779 First fiscal year in the series	€ 318,595 Equity 2023: € 318,595 ▲ 36% vs 2022 (€ 233,779) Favourable step	€ 413,174 Equity 2024: € 413,174 ▲ 30% vs 2023 (€ 318,595) Favourable step	€ 405,049 Equity 2025: € 405,049 ▼ 2% vs 2024 (€ 413,174) Unfavourable step	▼ 2%
Total debts	€ 68,047 Total debts 2022: € 68,047 First fiscal year in the series	€ 27,830 Total debts 2023: € 27,830 ▼ 59% vs 2022 (€ 68,047) Favourable step	€ 14,627 Total debts 2024: € 14,627 ▼ 47% vs 2023 (€ 27,830) Favourable step	€ 37,850 Total debts 2025: € 37,850 ▲ 159% vs 2024 (€ 14,627) Unfavourable step	▲ 159%
Cash	€ 228,456 Cash 2022: € 228,456 First fiscal year in the series	€ 302,109 Cash 2023: € 302,109 ▲ 32% vs 2022 (€ 228,456) Favourable step	€ 124,609 Cash 2024: € 124,609 ▼ 59% vs 2023 (€ 302,109) Unfavourable step	€ 89,158 Cash 2025: € 89,158 ▼ 28% vs 2024 (€ 124,609) Unfavourable step	▼ 28%
Retained profit	€ 215,179 Retained profit 2022: € 215,179 First fiscal year in the series	€ 299,995 Retained profit 2023: € 299,995 ▲ 39% vs 2022 (€ 215,179) Favourable step	€ 394,574 Retained profit 2024: € 394,574 ▲ 32% vs 2023 (€ 299,995) Favourable step	€ 386,449 Retained profit 2025: € 386,449 ▼ 2% vs 2024 (€ 394,574) Unfavourable step	▼ 2%
Dividend	€ 30,000 Dividend 2022: € 30,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 30,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 104,557 Dividend 2025: € 104,557 Unchanged (€ 0) Unchanged
Bank debt	€ 19,372 Bank debt 2022: € 19,372 First fiscal year in the series	€ 5,738 Bank debt 2023: € 5,738 ▼ 70% vs 2022 (€ 19,372) Favourable step	€ 284 Bank debt 2024: € 284 ▼ 95% vs 2023 (€ 5,738) Favourable step	€ 20 Bank debt 2025: € 20 ▼ 93% vs 2024 (€ 284) Favourable step	▼ 93%
Balance sheet total	€ 301,826 Balance sheet total 2022: € 301,826 First fiscal year in the series	€ 346,424 Balance sheet total 2023: € 346,424 ▲ 15% vs 2022 (€ 301,826) Unchanged	€ 427,801 Balance sheet total 2024: € 427,801 ▲ 23% vs 2023 (€ 346,424) Unchanged	€ 442,899 Balance sheet total 2025: € 442,899 ▲ 4% vs 2024 (€ 427,801) Unchanged	▲ 4%

Key figures of DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE?

What happened at DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 4, 2026 New annual accounts for financial year 2025: profit of € 96,432 (▲ 2% vs 2024). filed late Source: NBB ↗
2015 Dedobbeleer DR Chantal Dedobbeleer became a director. NBB
Jan 29, 2015 New establishment in Nivelles. KBO
Jan 29, 2015 Start of the company according to the CBE. KBO

In short

From € 66,176 profit in 2022 to € 96,432 profit in 2025.

Paid € 135,574 in corporate taxes since 2022.

Best year ever: 2025, with € 96,432 profit.

Paid out € 134,557 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE? We notify you, reason included.

Follow DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Dedobbeleer DR Chantal Dedobbeleer

DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE

Behind DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE is Dedobbeleer DR Chantal Dedobbeleer.

See the full network in the app

Directors

According to the 2025 annual accounts

Dedobbeleer DR Chantal Dedobbeleer

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Allée Pré Lorette 4

1400 Nivelles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0597.598.885
VAT number: BE 0597.598.885
Registered office: Allée Pré Lorette 4, 1400 Nivelles
Names & denominations: DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE · Dr. Chantal Dedobbeleer
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 January 2015
Peppol: Active · Active since 24 Feb 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗